Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gsk 3 inhibitor 1'

Search results for: 'gsk 3 inhibitor 1'

Items 91-100 of 180

Page
per page
  1. GSK2636771
    B2186 GSK2636771
    Target: PI3K
    Summary: PIK3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.83 mg/mL
  2. BX795
    A8222 BX795
    Summary: PDK1 inhibitor
      ≥59.1 mg/mL
  3. BAY 80-6946 (Copanlisib)
    B2178 BAY 80-6946 (Copanlisib)
     1 Citation
    Target: PI3K
    Summary: PI3K inhibitor
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  4. TGX-221
    A2681 TGX-221
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent,selective and ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL
  5. XL388
    A3940 XL388
    Summary: MTOR inhibitor,highly potent and selective
      insoluble in EtOH; insoluble in H2O; ≥6.87 mg/mL
  6. ETP-46464
    A8626 ETP-46464
    Target: PI3K|mTOR|DNA-PK|ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥16.13 mg/mL
  7. GDC-0941 dimethanesulfonate
    A3432 GDC-0941 dimethanesulfonate
    Summary: PI3K inhibitor
      insoluble in H2O; insoluble in EtOH; ≥207.6 mg/mL
  8. LY2584702
    B5815 LY2584702
    Target: p70 rsk
    Summary: p70 S6 kinase inhibitor
      ≥22.25 mg/mL
  9. GDC-0068 (RG7440)
    A3006 GDC-0068 (RG7440)
    Target: Akt
    Summary: Pan-AKT inhibitor,highly selective
      ≥22.9 mg/mL
  10. Miltefosine
    B1371 Miltefosine
    Target: PI3K
    Summary: PI3K/Akt inhibitor
      ≥10.2 mg/mL

Items 91-100 of 180

Page
per page
Shop By
Now Shopping by
  1. Category PI3K/Akt/mTOR Signaling Remove This Item
Clear All
Shopping Options
Category
  1. Akt 29item
  2. AMPK 8item
  3. CK2 8item
  4. DNA-PK 5item
  5. eNOS 2item
  6. GSK-3 17item
  7. MELK 2item
  8. mTOR 29item
  9. PI3K 62item
  10. PI4K 1 item
  11. PDK-1 8item
  12. PIKfyve 1 item
  13. PKB 1 item
  14. S6 Kinase 8item
Specificity
  1. Selective 63item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 13item
  4. PI3K 36item
  5. mTOR 22item
  6. GSK-3 10item
  7. Eph Receptors 1 item
  8. VEGFR 1 item
  9. PDGFR 1 item
  10. Bcr-Abl 1 item
  11. Pim 1 item
  12. Ribosomal s6 kinases (RSK) 1 item
  13. Src 1 item
  14. DNA-PK 8item
  15. AMPK 3item
  16. S6 kinases 1 item
  17. ERK 1 item
  18. PKC 2item
  19. PKG 1 item
  20. PKA 3item
  21. MELK 1 item
  22. NUAK1 1 item
  23. NUAK2 1 item
  24. RSK 1 item
  25. ATM/ATR 2item
  26. CK2 3item
  27. HIPK2 1 item
  28. HIPK3 1 item
  29. P110 1 item
  30. Hck 1 item
  31. p70 rsk 3item
  32. PDK-1 1 item
  33. Prk 1 item
  34. NUAK 1 item
  35. NOS 1 item
  36. PIM1 kinase 1 item
  37. phospholipase A2 1 item
  38. ATM 1 item
  39. PIKfyve 1 item
  40. p90 S6K 1 item
Reported Experiments
  1. Animal Experiments 80item
  2. Cell Experiments 61item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Bladder Cancer 1 item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 14item
  6. Cancer 51item
  7. Cervical Cancer 1 item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Colon Cancer 3item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 2item
  13. Diabetes 1 item
  14. Glioblastoma 5item
  15. Glioma 5item
  16. Hepatocellular Carcinoma 1 item
  17. Leukemia 1 item
  18. Lung Cancer 6item
  19. Melanoma 2item
  20. Neuroblastoma 2item
  21. Non-small Cell Lung Cancer 1 item
  22. Ovarian Cancer 4item
  23. Pancreatic Cancer 6item
  24. Prostate Cancer 5item
  25. Renal Cancer 1 item
  26. Rheumatoid Arthritis 1 item
  27. Type 2 Diabetes 1 item